Fidelity Investments
ARMP icon

Fidelity Investments’s Armata Pharmaceuticals ARMP Stock Holding History

Fidelity Investments’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$225 Buy
+22
New +$185 ﹤0.01% 5223
2022
Q2 		– Sell
-285
Closed -$1K – 4889
2022
Q1 		$1K Buy
+285
New +$1.46K ﹤0.01% 4756

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.06B AUM 11.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments's ARMP Position: Q1 2026 in Review

Fidelity Investments opened a new position in Armata Pharmaceuticals (ARMP) in Q1 2026: 22 shares worth $225. The stake represents ﹤0.01% of the portfolio and ranks #5223 among its holdings. This is a return to the name: Fidelity Investments previously reported a position in ARMP as recently as Q1 2022.

Fidelity Investments first reported a position in ARMP in Q1 2022 and has held it in 2 quarters since. The position peaked at $1K in Q1 2022. 45 funds tracked by Wall St. Rank hold ARMP as of Q1 2026.

  • Fidelity Investments held 22 shares of Armata Pharmaceuticals worth $225 as of Q1 2026.
  • Armata Pharmaceuticals was a new Fidelity Investments position in Q1 2026.
  • Armata Pharmaceuticals made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #5223 holding.
  • Fidelity Investments first reported a position in Armata Pharmaceuticals in Q1 2022 and has held it in 2 quarters since.
  • Fidelity Investments's Armata Pharmaceuticals position peaked at $1K in Q1 2022.
  • 45 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.